Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Letters: Observations

A Case of Fulminant Type 1 Diabetes With Graves’ Disease

  1. Yoshitaka Miura, MD,
  2. Atsushi Suzuki, MD,
  3. Ikuko Sato, MD,
  4. Yoko Kato, MD and
  5. Yutaka Oiso, MD
  1. 1From the First Department of Internal Medicine, Nagoya University School of Medicine, Nagoya, Japan
    Diabetes Care 2002 Oct; 25(10): 1894-1895. https://doi.org/10.2337/diacare.25.10.1894
    PreviousNext
    • Article
    • Info & Metrics
    • PDF
    Loading

    Type 1 diabetes is now classified as classic autoimmune (type 1A) and idiopathic (type 1B) diabetes. Fulminant type 1 diabetes was recently characterized as a novel subtype of type 1B diabetes. This disease was characterized as rapid onset, having an absence of diabetes-related autoantibodies, and having the presence of lymphocyte infiltration in exocrine pancreatic tissue without insulitis (1–3). Although fulminant type 1 diabetes has been clinically recognized, its etiology still remains obscure. In this article, we report a case of fulminant type 1 diabetes developed during pregnancy with manifested Graves’ disease, which was developed 1 year after onset of diabetes.

    A 28-year-old female was admitted to the hospital with diabetic ketoacidosis. She was 27 weeks pregnant and presented no symptom of preceding infection. After admission, she became comatose. Her arterial pH was 6.988 and she had marked elevation of ketone bodies. Her plasma glucose was 43.8 mmol/l; however, her HbA1c was 4.8%. Serum C-peptide was under the detection limit (<0.03 ng/ml), and urinary C-peptide was 0.86 μg/day. There was no response to a glucagon C-peptide stimulation test. Autoantibodies to the cytoplasm of islet, GAD, insulin, and tyrosine phosphate-like protein (IA-2) were all negative. Her serum amylase was 267 IU/l. Both her serum lipase and elastase 1 levels were elevated 55 IU/l and 1,200 ng/dl, respectively. These findings were consistent with symptoms of fulminant type 1 diabetes. Her fetus died, and artificial abortion was performed. The fetus had no superficial abnormality. The subject had HLA-DRB1*0101/*0901, DQB1-*0612/*0306, A2/A24 (9), B7/B61 (40), and Cw7. She was in a euthyroid state, and autoantibodies to the thyroid were negative at that time.

    After 1 year she presented overt thyrotoxic symptoms such as hyperhydrosis, palpitation, finger tremor, and poor glycemic control. Her thyroid hormones were elevated, and the thyroid-stimulating hormone receptor antibody was positive. She was diagnosed with Graves’ disease and administered propylthiouracil. Her glycemic control was fair with continuous subcutaneous insulin infusion. Diabetes-related autoantibodies were still negative, and her intrinsic insulin secretion was scant. Like a previous short report (4), our case had immunogenetic characteristics of an autoimmune disease except for endocrine pancreas. We often observed classic type 1A diabetes associated with autoimmune thyroid disease. This case was unique in that diabetes developed during pregnancy and was complicated with autoimmune disease. This case may help clarify the etiology of this disease entity.

    Footnotes

    • Address correspondence to Yoshitaka Miura, First Department of Internal Medicine, Nagoya University School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550 Japan, E-mail: ymiura64{at}med.nagoya-u.ac.jp.

    • DIABETES CARE

    References

    1. ↵
      Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y: A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies: Osaka IDDM Study Group. N Engl J Med 342: 301–307, 2000
      OpenUrlCrossRefPubMedWeb of Science
    2. Sekine N, Motokura T, Oki T, Umeda Y, Sasaki N, Hayashi M, Sato H, Fujita T, Kaneko T, Asano Y, Kikuchi K: Rapid loss of insulin secretion in a patient with fulminant type 1 diabetes mellitus and carbamazepine hypersensitivity syndrome. JAMA 285: 1153–1154, 2001
      OpenUrlCrossRefPubMed
    3. ↵
      Tanaka S, Kobayashi T, Momotsu T: A novel subtype of type 1 diabetes mellitus. N Engl J Med 342: 1835–1837, 2000
      OpenUrlCrossRefPubMed
    4. ↵
      Sakaue S, Nagata M, Wakabayashi O, Honda T, Yoshimura H, Yamaguchi E, Nishimura M: A case of fulminat type 1 diabetes with elevated rheumatoid factor and the temporal presence of thyroid-stimulating hormone receptor antibody (Letter). Diabetes Care 25: 935–936, 2002
      OpenUrlFREE Full Text
    PreviousNext
    Back to top
    Diabetes Care: 25 (10)

    In this Issue

    October 2002, 25(10)
    • Table of Contents
    • About the Cover
    • Index by Author
    Sign up to receive current issue alerts
    View Selected Citations (0)
    Print
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for your interest in spreading the word about Diabetes Care.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    A Case of Fulminant Type 1 Diabetes With Graves’ Disease
    (Your Name) has forwarded a page to you from Diabetes Care
    (Your Name) thought you would like to see this page from the Diabetes Care web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    A Case of Fulminant Type 1 Diabetes With Graves’ Disease
    Yoshitaka Miura, Atsushi Suzuki, Ikuko Sato, Yoko Kato, Yutaka Oiso
    Diabetes Care Oct 2002, 25 (10) 1894-1895; DOI: 10.2337/diacare.25.10.1894

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Add to Selected Citations
    Share

    A Case of Fulminant Type 1 Diabetes With Graves’ Disease
    Yoshitaka Miura, Atsushi Suzuki, Ikuko Sato, Yoko Kato, Yutaka Oiso
    Diabetes Care Oct 2002, 25 (10) 1894-1895; DOI: 10.2337/diacare.25.10.1894
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Footnotes
      • References
    • Info & Metrics
    • PDF

    Related Articles

    Cited By...

    More in this TOC Section

    • Weight Gain and Gestational Diabetes Mellitus Is a Sensitive Issue
    • Beneficial Effects of a 4-Week Exercise Program on Plasma Concentrations of Adhesion Molecules
    • Malignant Melanoma Misdiagnosed as a Diabetic Foot Ulcer
    Show more Letters: Observations

    Similar Articles

    Navigate

    • Current Issue
    • Standards of Care Guidelines
    • Online Ahead of Print
    • Archives
    • Submit
    • Subscribe
    • Email Alerts
    • RSS Feeds

    More Information

    • About the Journal
    • Instructions for Authors
    • Journal Policies
    • Reprints and Permissions
    • Advertising
    • Privacy Policy: ADA Journals
    • Copyright Notice/Public Access Policy
    • Contact Us

    Other ADA Resources

    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • Scientific Sessions Abstracts
    • Standards of Medical Care in Diabetes
    • BMJ Open - Diabetes Research & Care
    • Professional Books
    • Diabetes Forecast

     

    • DiabetesJournals.org
    • Diabetes Core Update
    • ADA's DiabetesPro
    • ADA Member Directory
    • Diabetes.org

    © 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.